The Cardiovascular Business Unit delivers comprehensive solutions across interventional cardiology, structural heart, heart failure, CRM, electrophysiology, endovascular, and cardiac surgery. We are a preferred partner for both established and emerging technologies, bringing cutting-edge innovations, clinical expertise, and training that enable cardiac teams in Southeast Asia to improve patient outcomes.